Lonza Group AG against Sanofi — live side-by-side technical comparison.
Prices as of 2026-09-23T15:30:29+00:00 UTC · updates daily
LONN.SW leads 5 of the 5 windows we measure — over 1 month LONN.SW is -4.4% and SNY -8.8%; over year to date LONN.SW is +4.5% and SNY -14.0%.
| LONN.SW | SNY | |
|---|---|---|
| Price | $561.80 | $41.66 |
| 1 day | -0.2%lead | -2.0% |
| 5 days | +4.3%lead | -2.2% |
| 1 month | -4.4%lead | -8.8% |
| 6 months | +20.2%lead | -7.0% |
| Year to date | +4.5%lead | -14.0% |
| 52-week position | 75% of range | 7% of range |
| 52-week range | $454.60–$597.80 | $40.89–$52.68 |
| vs 50-day average | below $564.23 | below $43.82 |
| vs 200-day average | above $530.05 | below $45.32 |
| RSI (14) | 38 | 25 |
| Next earnings | 2026-01-28 | 2026-10-30 |
LONN.SW trades at $561.80, below its 50-day average of $564.23, and above the 200-day at $530.05. It sits at 75% of its 52-week range ($454.60–$597.80); 14-day RSI is 38, in neutral territory; an average session moves it about 1.9%. For levels, the first level overhead is $564.23 (0.4% away) and the first support below is $554.70 (1.3% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
SNY trades at $41.66, below its 50-day average of $43.82, and below the 200-day at $45.32. It sits at 7% of its 52-week range ($40.89–$52.68); 14-day RSI is 25, in oversold territory; an average session moves it about 1.7%. For levels, the first level overhead is $42.31 (1.6% away) and the first support below is $41.33 (0.8% down). On the checklist the page runs for every asset, 0 of 6 checks read bullish — the lean is bearish.
Both move about the same amount day to day (1.9% and 1.7% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: LONN.SW clearing $564.23 or losing $554.70; SNY clearing $42.31 or losing $41.33. Until one of them gives way, the relative reading above stands.